177 related articles for article (PubMed ID: 25034527)
1. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
[TBL] [Abstract][Full Text] [Related]
2. PTPRO exaggerates inflammation in ulcerative colitis through TLR4/NF-κB pathway.
Zhao J; Yan S; Zhu X; Bai W; Li J; Liang C
J Cell Biochem; 2020 Feb; 121(2):1061-1071. PubMed ID: 31452237
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Wang L; Zhu R; Huang Z; Li H; Zhu H
Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
[TBL] [Abstract][Full Text] [Related]
4. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
[TBL] [Abstract][Full Text] [Related]
5. Aggravated Liver Injury but Attenuated Inflammation in PTPRO-Deficient Mice Following LPS/D-GaIN Induced Fulminant Hepatitis.
Wang X; Yan S; Xu D; Li J; Xie Y; Hou J; Jiang R; Zhang C; Sun B
Cell Physiol Biochem; 2015; 37(1):214-24. PubMed ID: 26303994
[TBL] [Abstract][Full Text] [Related]
6. PTPRO activates TLR4/NF-κB signaling to intensify lipopolysaccharide-induced pneumonia cell injury.
Chen Y; Sun B
Allergol Immunopathol (Madr); 2022; 50(3):119-124. PubMed ID: 35527665
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4.
Wei X; Liu H; Li X; Liu X
Ann Hepatol; 2019; 18(6):869-878. PubMed ID: 31477445
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
[TBL] [Abstract][Full Text] [Related]
9. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3.
Hou J; Xu J; Jiang R; Wang Y; Chen C; Deng L; Huang X; Wang X; Sun B
Hepatology; 2013 Feb; 57(2):678-88. PubMed ID: 22821478
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
Zhao N; Wang R; Zhou L; Zhu Y; Gong J; Zhuang SM
Mol Cancer; 2014 Feb; 13():35. PubMed ID: 24565101
[TBL] [Abstract][Full Text] [Related]
12. PTPRO Promotes Oxidized Low-Density Lipoprotein Induced Oxidative Stress and Cell Apoptosis through Toll-Like Receptor 4/Nuclear Factor κB Pathway.
Liang C; Wang X; Hu J; Lian X; Zhu T; Zhang H; Gu N; Li J
Cell Physiol Biochem; 2017; 42(2):495-505. PubMed ID: 28578349
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HULC promotes lung squamous cell carcinoma by regulating PTPRO via NF-κB.
Xu Y; Li J; Wang P; Zhang Z; Wang X
J Cell Biochem; 2019 Dec; 120(12):19415-19421. PubMed ID: 31448453
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.
Hsu SH; Motiwala T; Roy S; Claus R; Mustafa M; Plass C; Freitas MA; Ghoshal K; Jacob ST
J Cell Biochem; 2013 Aug; 114(8):1810-8. PubMed ID: 23533167
[TBL] [Abstract][Full Text] [Related]
15. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
[TBL] [Abstract][Full Text] [Related]
16. Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA.
Chen IT; Cheng AC; Liu YT; Yan C; Cheng YC; Chang CF; Tseng PH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955552
[TBL] [Abstract][Full Text] [Related]
17. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
18. The lncARSR/PTEN/Akt/nuclear factor-kappa B feedback regulatory loop contributes to doxorubicin resistance in hepatocellular carcinoma.
Li Y; Li J; Chen H; Wang J; Jiang L; Tan X
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23119. PubMed ID: 35678308
[TBL] [Abstract][Full Text] [Related]
19. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.
Wang Z; Yan J; Lin H; Hua F; Wang X; Liu H; Lv X; Yu J; Mi S; Wang J; Hu ZW
Hepatology; 2013 May; 57(5):1869-81. PubMed ID: 23299825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
